Filing Flows › 8-K events › Hinge Health
Hinge Health: results of operations
Form 8-K filed Nov 2, 2026 · items 2.02, 5.02, 7.01
Results of operationsHinge Health reports record third quarter 2026 financial results
What the filing says
Hinge Health reports record third quarter 2026 financial results • Revenue increased 52% year-over-year to $235 million
ScaleThe filing names $235.0M: about 25% of Hinge Health's annual revenue ($939.9M, four times the latest quarter).
Read the filing on SEC EDGAR →
What usually followsAcross 69,115 8-Ks reporting Item 2.02 (results of operations) in our universe, the stock's median move the next session was +0.2% (typical size ±3.6%, up 51% of the time); over the following 21 sessions, +1.2%. Item 5.02: −0.1% next session across 39,174. Every item ranked →
What this kind of filing means
Item 5.02 — Departure or appointment of directors and officers. Leadership changes: who leaves, who arrives and on what terms. A sudden CEO or CFO departure without a successor deserves attention.
Hinge Health at a glance
Hinge Health, Q3 2026: revenue $235M (+52% year over year), operating margin 21.4%. The chart follows the revenue to costs, profit and cash.
Hinge Health: every quarter, Q/Q and Y/Y, holders and guidance →
Other recent guidance
- Airsculpt Technologies Nov 6, 2026
- Terawulf Nov 6, 2026
- Plains GP Holdings LP Nov 6, 2026
- PSQ Holdings Nov 6, 2026
- Plains All American Pipeline LP Nov 6, 2026
- Concentra Group Holdings Parent Nov 5, 2026
- Conduent Nov 5, 2026
- Teads Holding Nov 5, 2026
- iSpecimen Nov 5, 2026
- Nano Dimension Nov 5, 2026
Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.